<DOC>
	<DOCNO>NCT02817906</DOCNO>
	<brief_summary>This randomize , double-blind , placebo-controlled study compare efficacy safety ITI-007 versus placebo administer orally daily treatment agitation patient dementia , include Alzheimer 's disease .</brief_summary>
	<brief_title>ITI-007 Treatment Agitation Patients With Dementia , Including Alzheimer 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Psychomotor Agitation</mesh_term>
	<criteria>Clinical diagnosis probable Alzheimer 's disease Clinically significant symptom agitation secondary probable Alzheimer 's disease Able attend outpatient clinic visit primary caregiver Unable comply study procedure Considered medically inappropriate study participation</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>